We are live on ! Find out more
OFM

Omega Fund Management Portfolio holdings

AUM $163M
1-Year Est. Return 107.06%
This Fund
S&P 500
This Quarter Est. Return
+20.53%
1 Year Est. Return
+107.06%
3 Year Est. Return
+111.75%
5 Year Est. Return
+84.24%
10 Year Est. Return
+495.59%
AUM
$160M
AUM Growth
+$6.4M
Cap. Flow
-$6.43M
Cap. Flow %
-4.01%
Top 10 Hldgs %
99.56%
Holding
11
New
–
Increased
–
Reduced
3
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
KYNB
Kyntra Bio
KYNB
+$5.15M
2
PVLA
Palvella Therapeutics
PVLA
+$1.21M
3
NBRV
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
+$72.2K

Sector Composition

Rank Sector Weight
1 Healthcare 76.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRTK
1
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$62.7M 39.11%
2,600,410
– –
JUNO
2
DELISTED
Juno Therapeutics, Inc.
JUNO
$36.8M 22.93%
1,229,512
– –
KYNB
3
Kyntra Bio
KYNB
$28.5M
$20.3M 12.65%
25,100
-7,400
-23% -$5.15M
NBRV
4
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$11.9M 7.45%
4,556
-28
-0.6% -$72.2K
JNCE
5
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$8.13M 5.07%
579,650
– –
PVLA
6
Palvella Therapeutics
PVLA
$1.98B
$6.92M 4.32%
17,091
-4,126
-19% -$1.21M
EGLT
7
DELISTED
Egalet Corporation
EGLT
$6.85M 4.27%
2,889,926
– –
CDTX
8
DELISTED
Cidara Therapeutics
CDTX
$3.34M 2.08%
22,248
– –
CBAY
9
DELISTED
Cymabay Therapeutics
CBAY
$1.74M 1.08%
301,477
– –
EPIX
10
DELISTED
ESSA Pharma
EPIX
$933K 0.58%
84,848
– –
DRNA
11
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$708K 0.44%
223,457
– –

Similar funds

HCCM
Hudson Canyon Capital Management New York $163M AUM 33.71% 1-Year Est. Return
PBO
Peoples Bank (Ohio) Marietta, Ohio $163M AUM 18.72% 1-Year Est. Return
PCR
Potrero Capital Research San Francisco, California $163M AUM 79.07% 1-Year Est. Return
BCM
Basso Capital Management Stamford, Connecticut $163M AUM 21.95% 1-Year Est. Return
IVGAI
Index Venture Growth Associates IV St. Helier, Jersey $163M AUM 54.88% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
TCGDR
TB Capital Gestao de Recursos Rio De Janeiro $163M AUM 20.86% 1-Year Est. Return
IPWA
International Private Wealth Advisors San Diego, California $163M AUM 16.99% 1-Year Est. Return

Omega Fund Management's Q2 2017 Portfolio in Review

As of Q2 2017, Omega Fund Management held 11 positions worth $160M, up 4.2% from $154M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Omega Fund Management withdrew a net $6.43M in Q2 2017, reducing 3 holdings. Its largest reduction was Kyntra Bio, cutting an estimated $5.15M.

By sector, the portfolio is most concentrated in Healthcare at 77% of assets, down from 82% a quarter earlier.

  • Omega Fund Management's biggest Q2 2017 reduction was Kyntra Bio, cutting an estimated $5.15M.
  • Omega Fund Management's ten largest holdings make up 100% of its $160M portfolio in Q2 2017.
  • Omega Fund Management opened 0 new positions and closed 0 in Q2 2017.
  • Omega Fund Management's portfolio value rose 4.2% quarter-over-quarter to $160M.

Based on Omega Fund Management's 13F filing for Q2 2017, filed 26 Jul 2017.